Composition of a drug delivery complex and the method of preperation thereof

IN607590BActive Publication Date: 2026-10-28UNIVERSITY OF PETROLEUM AND ENERGY STUDIES
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
IN202411071609
Authority / Receiving Office
IN · IN
Patent Type
Patents
Current Assignee / Owner
Filing Date
2024-09-23
Publication Date
2026-10-28
Estimated Expiration
2044-09-23

AI Technical Summary

Technical Problem

Current drug delivery systems for plant-derived anti-cancer molecules like naringenin face challenges such as low solubility, bioavailability, and stability, particularly when used in their free form, which limits their effectiveness in treating cancer without harming healthy tissues.

Method used

A drug delivery system is developed using carboxylic acid-modified MXene (Ti3C2-CA) as a carrier, optimized for loading naringenin through a synthesis process involving LiF, HCl, and NaOH, followed by chloroacetic acid treatment to enhance bioavailability and stability, with characterization using UV-spectroscopy, XRD, and other techniques to confirm successful loading and stability.

Benefits of technology

The naringenin-loaded MXene delivery system improves the bioavailability, thermal stability, and pH-dependent sustained release of naringenin, addressing the limitations of its free form by increasing loading capacity and stability, and enhancing therapeutic efficacy.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention discloses a composition of drug delivery complex comprising: a loading compound including varying concentrations of naringenin loaded onto various concentrations of a carrier compound as a carboxylic acid-modified MXene (Ti3C2-CA). The present invention also discloses the method of preparation of the drug delivery complex, wherein Ti3C2Tix is firstly prepared, followed by synthesis of carboxylic acid-modified MXene (Ti3C2-CA) and finally synthesis of a NAG- Ti3C2-CA delivery system.
Need to check novelty before this filing date? Find Prior Art

Description

FIELD OF THE INVENTIONThe present invention relates to a composition and the method of preparation of a drug delivery complex. More specifically, the present invention relates to a composition and the method of loading of a compound over a carrier.BACKGROUND OF THE INVENTIONMost anti-cancer drugs on the market today have a side effect that causes harm to healthy tissues in the vicinity of the tumour microenvironment. Bioactive molecules derived from plants are utilized to treat cancer to overcome these side effects. However, flavonoids and other bioactive molecules produced by plants have several drawbacks, including low solubility, low bioavailability, and less stability.CN117100688A: The invention discloses a mucous membrane adhesion type photo-thermal response nano gel and a preparation method and application thereof. The method comprises the steps of stably dispersing a two-dimensional photo-thermal nanomaterial by using bismaleimide-terminated Pluronic F127 to form an oil phase, forming a water phase by using a thiolated natural polymer aqueous solution, further mixing the oil phase with the water phase for ultrasonic emulsification to form a stable oil-in-water emulsion, and performing click reaction and crosslinking by using the thiolated maleimide at an oil-water interface to form the nano gel with the temperature-sensitive Pluronic F127 / two-dimensional photo-thermal nanomaterial as an inner core and coating the surface of the nano gel with the thiolated natural polymer. The nanogel provided by the invention has good biocompatibility and excellent affinity to mucin, and the sulfhydryl group on the surface of the nanogel can form disulfide bond with mucous membrane to adhere to the surface of the mucous membrane, so that the residence time of the nanogel on the mucous membrane is improved. The nano gel inner core can be loaded with hydrophobic drugs and applied to mucoadhesive drug delivery and can be combined with near infrared photothermal effect to realize the controlled release of the loaded drugs, so that the drug administrationefficiency is improved. (Abstract)US20240272078A1: A method of detecting an anti-cancer drug in a solution including contacting a substrate with the solution and measuring a Raman signal of the anti-cancer drug in the solution. The substrate includes a layer of a nanomaterial that is at least partially coated on an outer surface of the substrate. The nanomaterial includes silver nanoparticles and a V2CTx MXene, where Tx is at least one selected from the group consisting of hydroxide (-OH), oxygen (- O), and fluorine (-F). The anti-cancer drug interacts with the nanomaterial on the outer surface of the substrate in the solution. (Abstract)Sana 2023 et. al. Recent advances on MXene-based hydrogels for antibacterial and drug delivery applications: MXene is a flexible, compositionally diversified, and multilayered two-dimensional (2D) compound formed from surface-modified carbide. MXene is termed Mn+1XnTx, where M is an early transition metal, n = 1-3, and X is typically a layer of carbon or nitrogen and surface functional groups (Tx / Tz). MXenes offer a unique set of features, including high electrical conductivity, mechanical stability, magnetic properties, and remarkable visual capabilities. These materials have large surface areas, hydrophilicity, and other suitable physicochemical characteristics for drug delivery applications (e.g., high drug-loading capacity). Despite the versatile biomedical applications of MXenes and their composites, they have been exploited in two families of biomedical engineering materials: titanium carbide and tantalum carbide. By incorporating MXenes into hydrogel matrices, improved drug loading capacity, sustained release profiles, and enhanced stability is achievable; this integration helps the controlled release of MXene nanoparticles to afford sustained antibacterial activity, thus preventing bacterial colonization and biofilm formation. Overall, MXene-based hydrogels offer a promising platform for drug delivery and antibacterial applications. Their unique physicochemical properties and tunable surface chemistry allow for enhanced drug loading, controlled release, and targeted delivery. Notably, the inherent antimicrobialactivity of MXenes enables effective antibacterial therapy. Herein, recent advances pertaining to the antibacterial and drug delivery applications of MXene-based hydrogels are deliberated, focusing on crucial challenges and future perspectives. Their properties, synthesis techniques, and cytotoxicity are highlighted. The recent advances in improving 2D MXenes in the case of biodegradability and biocompatibility are also covered. (Abstract)Wang 2020 et. al. Chemistry of two-dimensional MXene nanosheets in theranostic nanomedicine: Transition metal carbide, carbonitride and nitride MXenes, as the emerging two-dimensional (2D) nanomaterials, have aroused burgeoning research interest in a broad range of applications ranging from energy conversion to biomedicines attributing to their distinctive planar nanostructure, physiochemical properties and biological effects. They are featured with fascinating electronic, optical, magnetic, mechanical and thermal properties, which exert significant roles in biomedical applications of 2D MXenes. In this review, we briefly summarize the recent research progress of 2D MXenes and highlight their intrinsic chemistry in theranostic nanomedicines, focusing on the synthetic chemistry for MXenes construction, surface chemistry for surface engineering, physiochemical property for theranostic application and biological chemistry for biosafety evaluation. Furthermore, based on the current achievements on MXenes, their potential research direction, critical challenges and future development in biomedicine are also discussed. It is highly expected that 2D MXene-based nanosystems would have a broad application prospect in theranostic biomedicine provided the current facing critical issues and challenges are adequately solved. (Abstract)The prior arts mentioned herein discusses various literature regarding role of MXene as a drug delivery carrier. However, the drug complex mentioned in the prior arts does not cater to all kinds of drug molecules like naringenin.Thereby, to overcome the drawbacks, there exists a need in the art to develop a composition of MXene with a plant derived anti-cancer molecule naringenin and amethod of preparation of a drug delivery system that could cater to wide variety of drug molecules especially plant derived naringenin.OBJECTS OF THE INVENTIONThe principal object of the present invention is to overcome the disadvantages of the prior art.An object of the present invention is to provide a composition of a drug delivery system.Another object of the present invention is to provide a method of preparation for a drug delivery system.The foregoing and other objects, features, and advantages of the present invention will become readily apparent upon further review of the following detailed description of the preferred embodiment as illustrated in the accompanying drawings.SUMMARY OF THE INVENTIONThe present invention relates to a composition and the method of preparation of a drug delivery system. More specifically, the present invention relates to a composition and the method of loading of a compound over a carrier.An aspect of the present invention discloses a composition of a drug delivery system through reaction optimization method, where, loading of compound consist of different concentrations: 0.5 mg of naringenin, 0.75 mg of naringenin, 1.0 mg of naringenin, 2.5 mg of naringenin, 5 mg of naringenin, 10 mg of naringenin and 15 mg of naringenin and a carrier compound consists of: 1 mg of carboxylic acid-modified MXene (Ti3C2-CA). Therefore, to optimize the loading of naringenin compound on carrier, the carrier compound ratio comprising: 0.5 mg to 10 mg of naringenin loaded onto 1 mg of carboxylic acid-modified MXene (Ti3C2-CA). After completing the optimization, 15 mg of naringenin loaded onto 20 mg of carboxylic acid-modified MXene (Ti3C2-CA).Another aspect of the present invention discloses a method of preparation of this drug delivery system comprising, adding LiF in a Teflon vessel in presence of HCl to obtain a mixture and stirring the obtained mixture for 5 minutes on a magnetic stirrer to obtain a stirred mixture, slowly adding Ti3AlC2 powder to the obtained stirred solution at 350C to obtain a synthesized product, washing the obtained synthesized product repeatedly with deionized water followed by diluted HCl, ethanol, and again with deionized water until the pH of the supernatant reached near neutral, ultra-sonicating and subsequently drying the obtained synthesized product to yield Ti3C2Tix which is a carrier for loading the naringenin compound, dissolving the obtained Ti3C2Tix in deionized water under a nitrogen environment and subsequently sonicating Ti3C2Tix in deionized water, adding NaOH under the nitrogen environment and subsequently stirring the obtained mixture at 60°C at 700 to 800 rpm for 2 hours to obtain a mixture, adding chloroacetic acid along with NaOH into the mixture obtained under the nitrogen environment and subsequently undergoing continuous stirring at 60° at 700 to 800 rpm to obtain a carboxylic group modified MXene Ti3C2 carrier, lyophilizing the compound obtained to yield a carboxylic acid-modified MXene (Ti3C2-CA), further, adding the Ti3C2-CA onto DMSO and subsequently stirred 40-45° at 700-800 rpm to obtain a solution, adding triethylamine (TEA) to the solution obtained and leave for a specific time of stirring at a required rpm of 40-45° to obtain a solution, adding a compound naringenin (NAG) to the solution obtained and leave for a specific time of stirring at a required rpm of 40-45° to obtain a NAG-loaded Ti3C2-CA drug delivery system; and conducting a thin layer chromatography (TLC) under varying concentrations of Ethyl acetate (Et): Hexane (Hx) solvent system to confirm the formation of NAG-loaded Ti3C2-CA drug delivery system based on the spot identification compared with the free form of NAG.While the invention has been described and shown with reference to the preferred embodiment, it will be apparent that variations might be possible that would fall within the scope of the present invention.BRIEF DESCRIPTION OF THE DRAWINGSThe summary above, as well as the following detailed description of illustrative embodiments, is better understood when read in conjunction with the appended drawings. To illustrate the present disclosure, exemplary constructions of the disclosure are shown in the drawings. However, the present disclosure is not limited to specific instrumentalities disclosed herein. Moreover, those in art will understand that the drawings are not too scale. Wherever possible, elements have been indicated by identical numbers.Embodiments of the present disclosure will now be described, by way of example only, with reference to the following diagrams wherein:Figure 1: Schematic representation of MXene-mediated delivery system with naringenin from synthesis to characterization.Figure 2: Reaction optimization and product formation confirmation by thin layer chromatography (TLC)Figure 3: (A) UV-Spectroscopy based characterization; (B) XRD based characterization; (C) FTIR based characterization to identify the functional groups, (D) EDS based characterization to identify the elements, (E) Zeta potential based characterization; (F) TGA based characterization to analyse the thermal stability; (G) SEM based characterization to see the size and surface modification; (H) TEM based characterization to see the surface of the 2D Ti3C2 and naringenin loaded 2D Ti3C2 as well as to confirm the loading of bioactive compounds on synthesized and surface modified 2D Ti3C2.DETAILED DESCRIPTION OF THE INVENTIONThe following description includes the preferred best mode of one embodiment of the present invention. It will be clear from this description of the invention that the invention is not limited to these illustrated embodiments but that the invention also includes a variety of modifications and embodiments thereto. Therefore, thepresent description should be seen as illustrative and not limiting. While the invention is susceptible to various modifications and alternative constructions, it should be understood, that there is no intention to limit the invention to the specific form disclosed, but, on the contrary, the invention is to cover all modifications, alternative constructions, and equivalents falling within the spirit and scope of the invention as defined in the claims.In any embodiment described herein, the open-ended terms "comprising," "comprises," and the like (which are synonymous with "including," "having" and "characterized by") may be replaced by the respective partially closed phrases "consisting essentially of," consists essentially of," and the like or the respective closed phrases "consisting of," "consists of, the like.As used herein, the singular forms "a," "an," and "the" designate both the singular and the plural, unless expressly stated to designate the singular only.The present invention relates to a composition and the method of preparation of a drug delivery system. More specifically, the present invention relates to a composition and the method of loading of a compound over a carrier.Most anti-cancer drugs on the market today have a side effect that causes harm to healthy tissues in the vicinity of the tumour microenvironment. Bioactive molecules derived from plants are utilized to treat cancer to overcome these side effects. However, flavonoids and other bioactive molecules produced by plants have several drawbacks, including low solubility, low bioavailability, and less stability. Naringenin, for example, is one of the best anti-cancer properties showing flavonoids produced from plants that, when given to cancer cells in free form, suffer from the drawbacks.With our invention, we were able to load more naringenin onto the surface of Ti3C2-MXene, a nanocarrier that increases naringenin's loading capacity and boosts its bioavailability. Furthermore, naringenin's thermal stability is improved by this newly developed delivery method over its free form. To increase thenumber of -COOH functional groups on the synthesized Ti3C2-MXene surface, the surface was exposed to -OH functional groups that were subsequently treated with chloroacetic acid and NaOH. These -COOH functional groups then take part in the esterification process, which creates a bond between naringenin and Ti3C2-MXene.MXene is a group of emerging 2D materials composed of transition metal carbides, carbonitrides and nitrides with the general formula of Mn+1XnTX, where M is an early transition metal, such as Sc, Ti, V, and Cr, X represents carbon or nitrogen and TX refers to surface termination molecules, such as single bond OH, single bond O or single bond F groups. One MXene sheet usually consists of 3, 5, or 7 atomic layers, corresponding to M2X, M3X2, or M4X3, respectively. There would be 2 more layers if the functional termination groups are presented and bonded to the outer transition metal layers. The termination layers are the common results from the synthesis in acidic fluoride-containing solution. Apart from single metal carbides, such as Ti3C2 and Ti4C3, compounds with binary metals also exist, including Mo2TiC2, Mo2Ti2C3. Because of their metallic conductivity (9880S cm-1), high Li storage capacity (447.8mAhg-1), ultrahigh theoretical capacitance (1982 F cm-3)

[56] and hydrophilic surfaces, MXene is generally viewed as promising materials for electrochemical energy conversion and storage devices1.Furthermore, Precise control over MXene thickness and size is crucial for enhancing their properties, including electrical conductivity, optical characteristics, surface catalysis and overall performances2.The glycoside portion of the monomer naringin, which has an intriguing chemical structure, is called naringenin (molecular formula: C15H12O5). It has a simple flavonoid skeleton of 15 carbon atoms and consists of three rings, two of which are benzene rings connecting the three carbon chains. Naringenin is chemicallynamed 4',5,7-trihydroxyflavone, with a molar mass of 272.3 and a melting point of 251.0 °C. In nature, naringenin exists in solid form and is almost insoluble in water but is soluble in organic solvents, such as ethanol, ether, dimethylformamide, and dimethyl sulfoxide. Naringenin is predominantly present in citrus fruits, including grapes, oranges, blood oranges, lemons, and grapefruit, with some studies indicating its high concentration in grapefruit peel. The compound has been associated with various beneficial effects3. 1. Brief about the workIn this work, an active naringenin-loaded Ti3C2-MXene delivery system has been synthesized by using LiF and HCl. Further, this developed delivery system was characterized by several techniques including UV-spectroscopy, X-ray diffraction, FTIR, TGA, Zeta potential, FE-SEM, EDS, and TEM. Based on the result of UV-Spectroscopy, XRD, and FTIR, the successful loading of naringenin on the surface of the Ti3C2-MXene has been analysed. Moreover, the delivery system's crystallite nature is also observed through X-ray diffraction. After the loading of the naringenin on the Ti3C2-MXene surface, the stability of Ti3C2-MXene has been increased characterized by zeta potential. Interestingly, the thermal stability of the Ti3C2-MXene has also been enhanced near 250 to 280°C after conjugating naringenin with Ti3C2-MXene. However, FE-SEM and TEM characterization indicated successful loading of naringenin on Ti3C2-MXene's surface.Figure 1 denotes the Schematic representation of MXene-mediated delivery system with naringenin from synthesis to characterization. Briefly, an aspect of the present invention discloses a composition of a drug delivery system through reaction optimization method, where, loading of compound consist of different concentrations: 0.5 mg of naringenin, 0.75 mg of naringenin, 1.0 mg of naringenin, 2.5 mg of naringenin, 5 mg of naringenin, 10 mg of naringenin and 15 mg of naringenin and a carrier compound consists of: 1 mg of carboxylic acid-modified MXene (Ti3C2-CA). Therefore, to optimize the loading of naringenin compound on carrier, the carrier compound ratio comprising: 0.5 mg to 10 mg ofnaringenin loaded onto 1 mg of carboxylic acid-modified MXene (Ti3C2-CA). After completing the optimization, 15 mg of naringenin loaded onto 20 mg of carboxylic acid-modified MXene (Ti3C2-CA).2. Synthesis Protocol2.1. Synthesis of Ti3C2Tix from Ti3AlC2To synthesize Ti3C2Tix, a specific amount of LiF was taken to a Teflon vessel that contained a specific molar concentration of HCl and kept for 5 mins of stirring on a magnetic stirrer. After 5 mins of stirring, slowly add Ti3AlC2 powder to the previous mixed solution and leave it for a specific time at 35°C. Then synthesized product was washed with deionized water followed by diluted HCl, ethanol, and again with deionized water until the pH of the supernatant reached near neutral. After completing these steps solution was ultra-sonicated for a time. After sonicating that mixed solution was dried to collect the Ti3C2Tix.2.2. Synthesis of Ti3C2-CA (Carboxyl-modified Ti3C2)To synthesize the Carboxyl-modified Ti3C2 that is Ti3C2-CA, the required amount of Ti3C2Tix -MXene dissolved in deionized water under a nitrogen environment for a time of sonication. After sonication, a specific amount of NaOH was added into the nitrogen environment-created reactor and stirred at 60°C at 700 to 800 rpm for 2 hours. Afterward, again NaOH and chloroacetic acid were added into the same reactor under the nitrogen environment and kept for a specific time of continued stirring at 60° at 700 to 800 rpm. After that carboxylic acid-modified MXene (Ti3C2-CA) was dried through a lyophilize technique.2.3. Synthesis of Naringenin (NAG) -loaded-Ti3C2For the loading of naringenin on the surface of Ti3C2-CA, an optimized amount of Ti3C2-CA was added in DMSO and kept for an optimized time duration in stirring at 40-45° at 700-800 rpm. After proper mixing, add triethylamine (TEA) andleave for a specific time of stirring at a required rpm of 40-45°. Then optimized amount of naringenin was added to the solution and left for stirring at the same temperature and rpm. After a time, interval of stirring, 1,1'-Carbonyldiimidazole (CDI), a coupling reagent was added to the mixed solution of Ti3C2-CA and NAG and left for stirring at the required temperature for reaction. After completing this reaction, free NAG and NAG loaded with Ti3C2-CA were spotted on the TLC plate and ran in different concentrations (Fig.2) of Ethyl acetate: Hexane solvent system to ensure the delivery system formation.Figure 2 denotes reaction optimization and product formation confirmation by thin layer chromatography (TLC), wherein an embodiment of the present invention, states that the TLC parameters comprising, 10 mg compound with 20 mg carrier in 10 ml DMSO in 20 % Et;Hx, 5 mg compound with 1 mg carrier in 5 ml DMSO in 20 % Et;Hx, 5 mg compound with 1 mg carrier in 5 ml DMSO in 30 % Et;Hx, 5 mg compound with 1 mg carrier in 5 ml DMSO in 40 % Et;Hx, 15 mg compound with 1 mg carrier in 5 ml DMSO in 30 % Et;Hx, 5 mg compound with 1 mg carrier in 5 ml DMSO in 30 % Et;Hx, 0.5 mg compound with 1 mg carrier in 5 ml DMSO in 40 % Et;Hx, 0.75 mg compound with 1 mg carrier in 5 ml DMSO in 40 % Et;Hx, 1 mg compound with 1 mg carrier in 5 ml DMSO in 40 % Et;Hx, 2.5 mg compound with 1 mg carrier in 5 ml DMSO in 40 % Et;Hx and 15 mg compound with 1 mg carrier in 5 ml DMSO in 40 % Et;Hx.One of the most common solvent mixtures used in TLC is ethyl acetate-hexane. This provides a mixture of a relatively polar solvent (ethyl acetate) and a relatively non-polar solvent (hexane). The percentages of the two components can be varied to give a solvent mixture with the desired polarity.UV-Vis spectroscopy is an analytical technique that measures the amount of discrete wavelengths of UV or visible light that are absorbed by or transmitted through a sample in comparison to a reference or blank sample. This property is influenced by the sample composition, potentially providing information on whatis in the sample and at what concentration. Since this spectroscopy technique relies on the use of light, let's first consider the properties of light. 2.4. CharacterizationSynthesized Ti3C2Tix, Ti3C2-CA, Naringenin (NAG), and Naringenin coated MXene (Ti3C2_N) were characterized by different analytical techniques including UV-visible spectrometer (Shimadzu, UV-1900) (Fig.3A), XRD (PANalytical, Empyrean) (Fig.3B), Fourier transform infrared spectra- (PerkinElmer, Frontier) (Fig.3C), Zeta potential analyser (Fig.3E). Thermal stability (Fig.3F) of the Ti3AlC2, Ti3C2Tix, Ti3C2-CA, NAG, and Ti3C2_N was studied by the thermogravimetric analyzer (Hitachi High-Tech Science Corporation, NEXTA STA 200). The Ti3AlC2, synthesized Ti3C2Tix, and after coating the NAG on the surface of Ti3C2Tix, Field emission scanning electron microscopy (FESEM) (Fig.3G), was used to characterize the surface of each material and measure the size. Further, energy dispersive spectroscopy (EDS) (Fig.3D) was used to identify the composition of Ti3AlC2, synthesized Ti3C2Tix, and Ti3C2_N. Transmission electron microscope (TEM) (Fig.3H) was also used to record the images of synthesized Ti3C2Tix, and Ti3C2_N.Figure 3: (A) UV-Spectroscopy based characterization, was conducted on Ti3AlC2, Ti3C2Tix, carboxylic acid-modified MXene (Ti3C2-CA), naringenin (NAG) and NAG- Ti3C2-CA with the absorbance of UV arranged in the descending order: NAG- Ti3C2-CA (max absorbance at 228 nm, 290 nm and 344 nm)>NAG (max absorbance at 290 nm)> Ti3C2-CA (max absorbance at 226 nm)> Ti3C2Tix (max absorbance at 335 nm) > Ti3AlC2.The phenomena by which X-rays are reflected from the atoms in a crystalline solid is called diffraction. The diffracted X-rays generate a pattern that reveals structural orientation of each atom in each compound. X-ray diffraction is extensively used in chemistry for the characterization of organic and inorganic compounds that are made for pharmaceutical companies or making batteries of thecell phones. XRD finds the geometry or shape of a molecule using X-rays. This technique is based on the elastic scattering of X-rays from structures that have long range order (crystalline solids). XRD technique is divided into two categories based on the morphology and size of sample.Figure 3: XRD based characterization denotes the intensity as in the descending order: NAG- Ti3C2-CA >NAG > Ti3C2-CA > Ti3C2Tix > Ti3AlC2. FTIR is an absorption-based method that detects energy of molecular vibrations following illumination of infrared radiation on a sample. The transmitted radiation is detected, whereas the remaining is absorbed in the sample, and the unique bands arising from the resultant spectra are used to determine the chemical fingerprint of polymers.Figure 3: (C) FTIR based characterization to identify the functional groups, wherein highest transmission in the descending order: NAG- Ti3C2-CA >NAG > Ti3C2-CA > Ti3C2Tix > Ti3AlC2.Energy-dispersive X-ray spectroscopy (EDS, also abbreviated EDX or XEDS) is an analytical technique that enables the chemical characterization / elemental analysis of materials. A sample excited by an energy source (such as the electron beam of an electron microscope) dissipates some of the absorbed energy by ejecting a core-shell electron. A higher energy outer-shell electron then proceeds to fill its place, releasing the difference in energy as an X-ray that has a characteristic spectrum based on its atom of origin. This allows for the compositional analysis of a given sample volume that has been excited by the energy source. The position of the peaks in the spectrum identifies the element, whereas the intensity of the signal corresponds to the concentration of the element.Compositional information, down to the atomic level, can be obtained with the addition of an EDS detector to an electron microscope. As the electron probe isscanned across the sample, characteristic X-rays are emitted and measured; each recorded EDS spectrum is mapped to a specific position on the sample. The quality of the results depends on the signal strength and the cleanliness of the spectrum. Signal strength relies heavily on a good signal-to-noise ratio, particularly for trace element detection and dose minimization (which allows for faster recording and artifact-free results). Cleanliness will impact the number of spurious peaks seen; this is a consequence of the materials that make up the electron column.Figure 3 (D): Table 1: EDS based characterization to identify the elements, denotes the composition of elements for Ti3C2TixFigure 3 (D): Table 2. EDS based characterization to identify the elements, denotes the composition of elements for NAG- Ti3C2-CA The zeta potential is the electrical potential that exists in the shear plane of a particle, which is an imaginary surface that separates the thin liquid layer (composed of counter-ions) linked to the solid surface of particles in movement.This charge of the particles acts as an electrical barrier that impedes the coalescence of the particles, thereby helping to stabilize the suspension. In that sense, the zeta potential is a measure that can be used to draw conclusions about the electrostatic stabilization of droplets and particles. Therefore, it is an indirect measure of the physical stability of naringenin loaded Ti3C2 as denoted in Figure 3(E).Thermogravimetric analysis or thermal gravimetric analysis (TGA) is a method of thermal analysis in which the mass of a sample is measured over time as the temperature changes. This measurement provides information about physical phenomena, such as phase transitions, absorption, adsorption and desorption; as well as chemical phenomena including chemisorption, thermal decomposition, and solid-gas reactions (e.g., oxidation or reduction) as in Figure 3 (F).A scanning electron microscope (SEM) is a type of electron microscope that produces images of a sample by scanning the surface with a focused beam of electrons. The electrons interact with atoms in the sample, producing various signals that contain information about the surface topography and composition of the sample. The electron beam is scanned in a raster scan pattern, and the position of the beam is combined with the intensity of the detected signal to produce an image. In the most common SEM mode, secondary electrons emitted by atoms excited by the electron beam are detected using a secondary electron detector (Everhart-Thornley detector). The number of secondary electrons that can be detected, and thus the signal intensity, depends, among other things, on specimen topography.Transmission electron microscopy (TEM) is a microscopy technique in which a beam of electrons is transmitted through a specimen to form an image. The specimen is most often an ultrathin section less than 100 nm thick or a suspension on a grid. An image is formed from the interaction of the electrons with thesample as the beam is transmitted through the specimen. The image is then magnified and focused onto an imaging device, such as a fluorescent screen, a layer of photographic film, or a detector such as a scintillator attached to a chargecoupled device or a direct electron detector.Figure 3 (G) denotes the SEM based characterization to see the size and surface modification; Figure 3 (H) denotes TEM based characterization to see the surface of the 2D Ti3C2 and naringenin loaded 2D Ti3C2 as well as to confirm the loading of bioactive compounds on synthesized and surface modified 2D Ti3C2.The average thickness for Ti3C2Tix came as 270.25 nm and the average diameter for Ti3C2Tix came as 1163.70 nm and the average thickness for NAG- Ti3C2-CA came as 121.7 nm and the average diameter for NAG- Ti3C2-CA came as 282. 9 nm.2.5. Determination of loading % of the NAG on synthesized and surface-modified Ti3C2-CA carrier systemThe negative charge is present in both the carboxyl-modified Ti3C2-CA and the naringenin molecule. Therefore, we have loaded the naringin on it using the reaction methodology stated above. Using a drug loading efficiency formula, the loading percentage of the naringenin compound on the Ti3C2-CA carrier will be determined. The absorbance of the naringenin compound will be measured using a UV-vis spectrophotometer at room temperature to compute this.2.6. Determination of release study of NAG from synthesized and surface-modified Ti3C2-CA carrier systemNAG-loaded Ti3C2 (Ti3C2_N) will be dissolved in phosphate buffer saline solution and placed in a dialysis bag to assess the release profile of naringenin (NAG) from the surface-modified Ti3C2-CA carrier system. The release profile will be monitored at specific intervals based on differences in pH. Utilizing aroom-temperature UV-vis spectrophotometer, the absorbance of the naringenin compound will be measured.2.7. Biological evaluation of synthesized NAG-loaded Ti3C2(MXene)-CA delivery system.Cancer cell lines will be cultured in a BSL-2 facility to assess the synthesized NAG-loaded U3C2 (MXene)-CA delivery system in a biological system. Subsequent cytotoxic evaluation will be carried out using various concentrations of the synthetic delivery system.3. AdvantagesThis invention is focused on improving the major four technical aspects that need protection.1. This invented Naringenin loaded MXene-based delivery system will enhance the thermal stability of naringenin than its free form.2. This invented delivery system will also enhance the bioavailability of the naringenin than its free form.3. This invented delivery system will also enhance the pH-dependent sustained release of naringenin than its free form.References1. Weigu Li, Yun Huang, Yifei Liu, Marshall C. Tekell, Donglei (Emma) Fan, Three dimensional nanosuperstructures made of two-dimensional materials by design: Synthesis, properties, and applications, Nano Today, Volume 29, 2019, 100799, ISSN 1748-0132, https: / / doi.org / 10.1016 / j.nantod.2019.100799.2. Hilal, M., Yang, W., Hwang, Y. et al. Tailoring MXene Thickness and Functionalization for Enhanced Room-Temperature Trace NO2 Sensing. Nano-Micro Lett. 16, 84 (2024). https: / / doi.org / 10.1007 / s40820-023-01316-x3. Ji Cai, Hongli Wen, He Zhou, Dan Zhang, Dongfeng Lan, Songpo Liu, Chunyang Li, Xiaofang Dai, Tao Song, Xianyao Wang, Yuqi He, Zhixu He, Jun Tan, Jidong Zhang, Naringenin: A flavanone with antiinflammatory and anti-infective properties, Biomedicine & Pharmacotherapy, Volume 164, 2023, 114990, ISSN 0753-3322, https: / / doi.org / 10.10167j.biopha.2023.114990.While the present invention has been described with reference to embodiments, the embodiments are illustrative, and the scope of the invention is not limited to these embodiments. Many variations, modifications, additions, and improvements to the embodiments described above are possible. It is contemplated that these variations, modifications, additions, and improvements fall within the scope of the invention.

Claims

1. A composition of a drug delivery complex comprising: (a) a loading compound consists of: 0.5 mg of naringenin, 0.75 mg of naringenin, 1.0 mg of naringenin, 2.5 mg of naringenin, 5 mg of naringenin, 10 mg of naringenin and 15 mg of naringenin; (b) a carrier compound consists of: 1 mg of carboxylic acid-modified MXene (Ti3C2-CA) and 20 mg of carboxylic acid-modified MXene (Ti3C2-CA), wherein the loading compound: carrier compound ratio comprising: 0.5 mg to 10 mg of naringenin loaded onto 1 mg of carboxylic acid-modified MXene (Ti3C2-CA) and 15 mg of naringenin loaded onto 20 mg of carboxylic acid-modified MXene (Ti3C2-CA)2. A method of preparation of a drug delivery complex, the method comprising: (a) adding LiF in a Teflon vessel in presence of HCl to obtain a mixture and stirring the obtained mixture for 5 minutes on a magnetic stirrer to obtain a stirred mixture; (b) slowly adding Ti3AlC2 powder to the obtained stirred solution at 350C to obtain a synthesized product; (c) washing the obtained synthesized product repeatedly with deionized water followed by diluted HCl, ethanol, and again with deionized water until the pH of the supernatant reached near neutral; (d) ultra-sonicating and subsequently drying the obtained synthesized product to yield Ti3C2Tix; (e) dissolving the obtained Ti3C2Tix in deionized water under a nitrogen environment and subsequently sonicating Ti3C2Tix in deionized water; (f) adding NaOH under the nitrogen environment and subsequently stirring the obtained mixture at 60° at 700 to 800 rpm for 2 hours to obtain a mixture; (g) adding chloroacetic acid along with NaOH into the mixture obtained in step (f) under the nitrogen environment and subsequently undergoing continuous stirring at 60° at 700 to 800 rpm to obtain a compound; (h) lyophilizing the product obtained in step (g) to yield a carboxylic acid-modified MXene (Ti3C2-CA); (i) adding the Ti3C2-CA obtained in step h onto DMSO and subsequently stirred 40-45° at 700-800 rpm to obtain a solution; (j) adding triethylamine (TEA) to the solution obtained in step (i) and leave for a specific time of stirring at a required rpm of 40-45° to obtain a solution; (k) adding a compound naringenin (NAG) to the solution obtained in step (j) and leave for a specific time of stirring at a required rpm of 40-45° to obtain a NAG-Ti3C2-CA carrier complex; and (l) conducting a thin layer chromatography (TLC) under varying concentrations of Ethyl acetate (Et): Hexane (Hx) solvent system to separate the free NAG from the NAG- Ti3C2-CA carrier complex.

3. The method as claimed in claim 2, wherein the TLC parameters comprising: (a) 10 mg compound with 20 mg carrier in 10 ml DMSO in 20 % Et;Hx; (b) 5 mg compound with 1 mg carrier in 5 ml DMSO in 20 % Et;Hx; (c ) 5 mg compound with 1 mg carrier in 5 ml DMSO in 30 % Et;Hx; (d) 5 mg compound with 1 mg carrier in 5 ml DMSO in 40 % Et;Hx; (e ) 15 mg compound with 1 mg carrier in 5 ml DMSO in 30 % Et;Hx; (f) 5 mg compound with 1 mg carrier in 5 ml DMSO in 30 % Et;Hx; (g) 0.5 mg compound with 1 mg carrier in 5 ml DMSO in 40 % Et;Hx; (h) 0.75 mg compound with 1 mg carrier in 5 ml DMSO in 40 % Et;Hx; (i) 1 mg compound with 1 (j) 2.5 mg compound with (k) 15 mg compound with mg carrier in 5 ml DMSO in 40 % Et;Hx; 1 mg carrier in 5 ml DMSO in 40 % Et;Hx; and 1 mg carrier in 5 ml DMSO in 40 % Et;Hx.